Credit Suisse’s Opko Health OPK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $1.12M | Buy |
937,395
+41,377
| +5% | +$41.4K | ﹤0.01% | 2195 |
|
|
2023
Q4 | $1.35M | Buy |
896,018
+260,379
| +41% | +$376K | ﹤0.01% | 2143 |
|
|
2023
Q3 | $1.02M | Sell |
635,639
-15,891
| -2% | -$28.9K | ﹤0.01% | 2293 |
|
|
2023
Q2 | $1.41M | Buy |
651,530
+48,158
| +8% | +$75.3K | ﹤0.01% | 2153 |
|
|
2023
Q1 | $881K | Buy |
603,372
+62,348
| +12% | +$80.2K | ﹤0.01% | 2408 |
|
|
2022
Q4 | $676K | Buy |
541,024
+131,742
| +32% | +$208K | ﹤0.01% | 2594 |
|
|
2022
Q3 | $773K | Buy |
409,282
+4,549
| +1% | +$10.8K | ﹤0.01% | 2506 |
|
|
2022
Q2 | $1.02M | Sell |
404,733
-15,699
| -4% | -$45.8K | ﹤0.01% | 2360 |
|
|
2022
Q1 | $1.45M | Sell |
420,432
-38,846
| -8% | -$137K | ﹤0.01% | 2296 |
|
|
2021
Q4 | $2.21M | Buy |
459,278
+37,855
| +9% | +$153K | ﹤0.01% | 2712 |
|
|
2021
Q3 | $1.54M | Buy |
421,423
+34,609
| +9% | +$129K | ﹤0.01% | 3018 |
|
|
2021
Q2 | $1.57M | Sell |
386,814
-15,552
| -4% | -$61K | ﹤0.01% | 3044 |
|
|
2021
Q1 | $1.73M | Sell |
402,366
-439,615
| -52% | -$2.1M | ﹤0.01% | 2930 |
|
|
2020
Q4 | $3.33M | Sell |
841,981
-300,818
| -26% | -$1.26M | ﹤0.01% | 2419 |
|
|
2020
Q3 | $4.22M | Sell |
1,142,799
-248,093
| -18% | -$1.05M | ﹤0.01% | 1904 |
|
|
2020
Q2 | $4.74M | Buy |
1,390,892
+985,469
| +243% | +$2.21M | ﹤0.01% | 1739 |
|
|
2020
Q1 | $544K | Sell |
405,423
-202,263
| -33% | -$317K | ﹤0.01% | 3065 |
|
|
2019
Q4 | $893K | Buy |
607,686
+92,905
| +18% | +$156K | ﹤0.01% | 3215 |
|
|
2019
Q3 | $1.08M | Buy |
514,781
+35,970
| +8% | +$73.5K | ﹤0.01% | 2956 |
|
|
2019
Q2 | $1.17M | Buy |
478,811
+179,199
| +60% | +$391K | ﹤0.01% | 2834 |
|
|
2019
Q1 | $782K | Sell |
299,612
-44,294
| -13% | -$134K | ﹤0.01% | 3075 |
|
|
2018
Q4 | $1.03M | Buy |
343,906
+50,069
| +17% | +$170K | ﹤0.01% | 2750 |
|
|
2018
Q3 | $1.02M | Sell |
293,837
-90,808
| -24% | -$482K | ﹤0.01% | 2864 |
|
|
2018
Q2 | $1.81M | Sell |
384,645
-71,636
| -16% | -$272K | ﹤0.01% | 2553 |
|
|
2018
Q1 | $1.45M | Buy |
456,281
+68,869
| +18% | +$277K | ﹤0.01% | 2684 |
|
|
2017
Q4 | $1.9M | Buy |
387,412
+43,654
| +13% | +$253K | ﹤0.01% | 2473 |
|
|
2017
Q3 | $2.36M | Sell |
343,758
-166,338
| -33% | -$1.05M | ﹤0.01% | 2402 |
|
|
2017
Q2 | $3.36M | Sell |
510,096
-236,862
| -32% | -$1.66M | ﹤0.01% | 1875 |
|
|
2017
Q1 | $5.98M | Buy |
746,958
+410,445
| +122% | +$3.46M | 0.01% | 1527 |
|
|
2016
Q4 | $3.13M | Buy |
336,513
+32,847
| +11% | +$340K | ﹤0.01% | 2061 |
|
|
2016
Q3 | $3.22M | Buy |
303,666
+21,712
| +8% | +$216K | ﹤0.01% | 2012 |
|
|
2016
Q2 | $2.63M | Sell |
281,954
-455,692
| -62% | -$4.63M | ﹤0.01% | 2125 |
|
|
2016
Q1 | $7.66M | Buy |
737,646
+424,660
| +136% | +$3.88M | 0.01% | 1262 |
|
|
2015
Q4 | $3.15M | Sell |
312,986
-168,300
| -35% | -$1.69M | ﹤0.01% | 1949 |
|
|
2015
Q3 | $4.05M | Buy |
481,286
+311,080
| +183% | +$4.12M | ﹤0.01% | 1711 |
|
|
2015
Q2 | $2.74M | Buy |
170,206
+129,486
| +318% | +$2.01M | ﹤0.01% | 2291 |
|
|
2015
Q1 | $577K | Sell |
40,720
-10,913
| -21% | -$142K | ﹤0.01% | 3447 |
|
|
2014
Q4 | $516K | Buy |
51,633
+1,029
| +2% | +$8.81K | ﹤0.01% | 3689 |
|
|
2014
Q3 | $431K | Sell |
50,604
-34,824
| -41% | -$306K | ﹤0.01% | 3737 |
|
|
2014
Q2 | $755K | Buy |
85,428
+42,247
| +98% | +$369K | ﹤0.01% | 3534 |
|
|
2014
Q1 | $402K | Buy |
43,181
+14,085
| +48% | +$123K | ﹤0.01% | 3881 |
|
|
2013
Q4 | $246K | Buy |
+29,096
| New | +$294K | ﹤0.01% | 4210 |
|
Other funds holding OPK
RCMNY
PCM
Credit Suisse's OPK Position: Q1 2024 in Review
Credit Suisse increased its Opko Health (OPK) stake by 4.6% in Q1 2024, buying an estimated $41.4K and bringing the position to 937,395 shares worth $1.12M. The position accounts for ﹤0.01% of the portfolio, ranked #2195.
Credit Suisse first reported a position in OPK in Q4 2013 and has held it in 42 quarters since. The position peaked at $7.66M in Q1 2016. 226 funds tracked by Wall St. Rank hold OPK as of Q1 2024.
- Credit Suisse held 937,395 shares of Opko Health worth $1.12M as of Q1 2024.
- Credit Suisse bought 41,377 Opko Health shares in Q1 2024, an estimated $41.4K.
- Opko Health made up ﹤0.01% of Credit Suisse's portfolio in Q1 2024, its #2195 holding.
- Credit Suisse first reported a position in Opko Health in Q4 2013 and has held it in 42 quarters since.
- Credit Suisse's Opko Health position peaked at $7.66M in Q1 2016.
- 226 funds tracked by Wall St. Rank held Opko Health as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.